Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
AstraZeneca
Daiichi Sankyo
Fuji
Chubb
Healthtrust
Cerilliant
Queensland Health
Mallinckrodt

Generated: May 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin recombinant human

« Back to Dashboard

insulin recombinant human

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly HUMULIN R insulin recombinant human INJECTABLE;INJECTION 018780 NDA Eli Lilly and Company N 0002-8215-01
Lilly HUMULIN R insulin recombinant human INJECTABLE;INJECTION 018780 NDA Eli Lilly and Company N 0002-8215-17
Lilly HUMULIN R insulin recombinant human INJECTABLE;INJECTION 018780 NDA Eli Lilly and Company N 0002-8215-99
Lilly HUMULIN R insulin recombinant human INJECTABLE;INJECTION 018780 NDA Eli Lilly and Company N 0002-8501-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
US Department of Justice
Cipla
Daiichi Sankyo
Fish and Richardson
Harvard Business School
Johnson and Johnson
Healthtrust